首页> 美国卫生研究院文献>Springer Open Choice >A phase II study on the efficacy and safety of procedural analgesia with fentanyl buccal tablet in cancer patients for the placement of indwelling central venous access systems
【2h】

A phase II study on the efficacy and safety of procedural analgesia with fentanyl buccal tablet in cancer patients for the placement of indwelling central venous access systems

机译:II期研究使用芬太尼颊片剂进行程序性镇痛在癌症患者中放置留置中心静脉通路系统的有效性和安全性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPain in cancer patients is often related to oncologic therapies and diagnostic procedures. The placement of fully implantable venous access systems is a very common procedure in oncology patients. Local anaesthesia is the method most commonly used to overcome pain related to this surgical procedure, but the local anaesthetic may be unable to completely eradicate all pain. This study investigates the effectiveness and safety of fentanyl buccal tablet (FBT), administered by OraVescent® technology, in reducing procedural pain related to the placement of indwelling central venous access systems (Ports) in opioid-naïve cancer patients.
机译:背景癌症患者的疼痛通常与肿瘤治疗和诊断程序有关。在肿瘤患者中,完全植入式静脉通路系统的放置是非常常见的过程。局麻是最能克服与该手术相关的疼痛的方法,但是局麻可能无法完全消除所有疼痛。这项研究调查了由OraVescent®技术管理的芬太尼颊片剂(FBT)在减轻与阿片类药物初治癌症患者体内留置中心静脉通路系统(Ports)有关的程序性疼痛方面的有效性和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号